Welcome to our in-depth look at the Evolutionary Scale Model Launch. Today, we explore ESM3, a groundbreaking generative AI model launched by EvolutionaryScale on June 25, 2024.

Let's dive into the key features that make ESM3 a breakthrough in AI-driven biology.

ESM3 was trained on a vast dataset of 2.78 billion proteins, using 1 trillion teraflops of compute power, making it the most powerful model in biology.

Now, let's explore how ESM3 is set to impact scientific research.

EvolutionaryScale will provide an API for closed beta access and an open version of ESM3 for non-commercial use, fostering innovation in biological research.

Let's take a look at the funding and partnerships that have supported the development of ESM3.

Here are some insights from key figures at EvolutionaryScale.

"ESM3 takes a step toward a future of biology where AI is a tool to engineer from first principles, the way we engineer structures, machines, and microchips, and write computer programs." Alexander Rives, 2024

Let's take a look at the timeline of EvolutionaryScale and the development of ESM3.

July 2023: EvolutionaryScale was founded by a team of AI researchers who previously worked at Meta.

June 25, 2024: EvolutionaryScale launched ESM3, a milestone generative AI model for biology.

ESM3's relevance to the pharmaceutical industry cannot be overstated.

What does the future hold for EvolutionaryScale and ESM3?

In conclusion, the launch of ESM3 marks a significant milestone in the development of AI-driven biology.